South Florida LB Jacquian Williams could be good fit for Bears

SHARE South Florida LB Jacquian Williams could be good fit for Bears

Recently, when I was at EFT Performance in Highland Park, a player I didn’t recognized jumped out at me.

He was a smooth athlete, and I even thought he might have been a big receiver. But the player was Jacquian Williams, an outside linebacker from South Florida. You could tell he was explosive, which was confirmed at the South Florida Pro Day, when he ran a 4.53 and 4.72 in the 40-yard dash. But he also had a 36 1/2 inch vertical leap.

The Bears will host more than a dozen incoming rookies at Halas Hall later this month, and I would expect Williams to be in that group, or make a separate visit on his own.

That’s because it’s evident the Bears need some depth at the position, and team brass was at the South Florida Pro Day in force. Personnel executives Jerry Angelo and Tim Ruskell worked together with the Tampa Bay Buccaneers for several years, and Bears coach Lovie Smith often vacations in the area.

But Williams appeared to be one of the winners from that Pro Day. The big name, of course, was Terrell McClain, who is considered one of the more highly-rated defensive linemen. There was video of Bears defensive line coach Rod Marinelli working him out.

But Williams also turned some heads.

He came to South Florida as a junior college transfer, and he was named a team captain for his final season. Former USF head coach Jim Leavitt called him the “fastest linebacker” to ever play at the school.

He finished second-team All-BIG EAST, and he led the team with 71 tackles, including 11 for loss, 2 1/2 sacks and one interception.

USF coach Skip Holtz called him “his hero,” according to the St. Petersburg Times.

“He’s an incredibly unselfish young man. I don’t know that I’ve ever been around anybody as committed as he is, with the heart he has,” Holtz told the paper. “I hope my son grows up to be like Jacquian Williams. I feel that strongly about him as a young man.”

Williams isn’t projected to be a high draft pick, so he could be had in the later rounds.

At the NFL owners meeting in New Orleans, Smith about his depth at linebacker.

Specifically, I noted how fortunate his team has been because stud linebackers Brian Urlacher and Lance Briggs have been, for the most part, durable and performed at elite levels.

Many of the other players in the unit — because of the large investment in Briggs and Urlacher — have been cost-effective veterans or low-round draft picks. I asked Smith if he would like to add some youth at the position.

“You do. It’s a good question,” Smith said. “Brian and Lance have played a few years, and we’d like to get some younger players into the mix, at all of our positions. So, yes, that’s the case. And this year, you look, we don’t have a lot of linebackers signed. We have to bring some players in. But I like the play of our backups.”

I would guess he’s talking about players Nick Roach and Brian Iwuh, and maybe even Rod Wilson. But Pisa Tinoisamoa will be unrestricted, and he’s always been a Smith favorite.

But, with Briggs and Urlacher in their 30s, the Bears need some young players who can learn from these standouts. Williams can play on special teams, and he almost certainly would play outside linebacker, more specifically Briggs’ spot.

The Latest
Girls says the man is angry that she stood up for her mom in a disagreement about the couple’s sex and drinking habits.
Trout Unlimited’s Trout In The Classroom teaches young students about fish and the aquatic environment, capped by a day trip to get all wet.
From endorsing a new Bears’ stadium to revoking the subminimum wage, Johnson’s critics and allies examine where he and the city are going.
Businesses and neighborhood associations in River North and nearby want the city to end the dining program because of traffic congestion, delays to first responders and other headaches caused by closing off a major street artery, a local restaurant executive writes.
High doses become routine patient care even when they make patients so ill that they skip doses or stop taking the drugs. “There’s a gap in FDA’s authority that results in patients getting excess doses of a drug at excess costs,” says Dr. Mark Ratain.